Moderator:

Jessie Pindilli, BSN, RN
University of Wisconsin Hospital & Clinics
UWHC Comprehensive Program for Bleeding Disorders

 

Speaker:

Jennifer Maahs, RN-BC, MSN, PNP
Pediatric Nurse Practitioner
Indiana Hemophilia and Thrombosis Center, Indianapolis, IN

 

After completing this activity, the participant should be better able to:

  • Summarize the current FDA-approved products available for the management of patients with hemophilia.
  • Review 3 years of clinical data and ‘real-world’ experience with non-factor therapies
  • Describe the impact arthropathy and breakthrough bleeds while on prophylactic regimens with non-factor therapy has on patients with hemophilia.
  • Assess the impact of inhibitors when developing a treatment plan for patients with hemophilia.